Genome-wide DNA methylation profiles in precancerous conditions and cancers.
about
Role of epigenetic aberrations in the development and progression of human hepatocellular carcinomaCharacterization of chromosomal instability in murine colitis-associated colorectal cancer.Assembling pieces of the centromere epigenetics puzzle.Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancerViral hepatitis and hepatocellular carcinoma: etiology and managementPromoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis.A beta-mixture model for dimensionality reduction, sample classification and analysis.All y'all need to know 'bout retroelements in cancer.Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genesDiagnosis and prognostication of ductal adenocarcinomas of the pancreas based on genome-wide DNA methylation profiling by bacterial artificial chromosome array-based methylated CpG island amplification.Genetic and epigenetic alterations during renal carcinogenesis.Multilayer-omics analysis of renal cell carcinoma, including the whole exome, methylome and transcriptome.Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary diseaseCopy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterationsReduced 5-methylcytosine level as a potential progression predictor in patients with T1 or non-invasive urothelial carcinomaBody mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study.DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort studyEpigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.Chemistry of nucleic acids: impacts in multiple fields.Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric CancerChronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.Methylation Profiling of Multiple Tumor Suppressor Genes in Hepatocellular Carcinoma and the Epigenetic Mechanism of 3OST2 RegulationSingle-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.DNA methyltransferase 3B expression is associated with poor outcome of stage I testicular seminomaA Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In VitroThe significance of epigenetic alterations in lung carcinogenesis.Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance.Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma.Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation.Retrotransposon-encoded reverse transcriptase in the genesis, progression and cellular plasticity of human cancer.Multilayer-omics analyses of human cancers: exploration of biomarkers and drug targets based on the activities of the International Human Epigenome Consortium.DNA secondary structures and epigenetic determinants of cancer genome evolution.Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma.Epigenetic modifications as therapeutic targets.
P2860
Q27023524-77F10EEE-5CA7-41D8-9A87-D96C40D9AAC0Q31026828-4BD46093-C78B-4F12-87CD-7C08198EFFB7Q33352751-E7C64523-2FA1-4B5C-868E-6507A8367235Q33587441-3C8A191E-C28E-43D2-89FA-CA4ECB7DCBB2Q33593219-F426CB02-A828-47B4-B7CB-F274EFF48666Q33826718-6D08F334-75AA-48EF-AF98-81965D2AE013Q33914431-6DF972FB-E9A9-4794-8A3B-2670E4130F09Q34143181-17B60A1E-99BA-46E1-8C43-0D3A9AD4359AQ34438914-F1CD82A8-BACA-45E2-BCBA-AFE9ABAF23C6Q34442914-5E9511A3-7948-473C-B69B-6AA98C228D3AQ34467232-8953473B-E6FE-46C4-94B6-6B57EDFE0A94Q34530994-8451CF6F-001A-4522-9ACF-940372201EB4Q34629271-1BA4128C-B50B-45B5-8FDC-9A652EDB6855Q34734078-49401BB9-0654-4428-AB62-85173A229018Q35016491-DF65EB0B-C3B5-4B3B-9923-DD1485571F03Q35163939-58807831-0EA6-4863-8D91-F4DCA6C5E502Q35224793-0A2DE254-715C-4D4D-A253-33045097878AQ35562690-47D0E78B-F076-4107-97F5-0A2872963091Q35585074-E82B9CFB-8D83-4150-8857-562DEBC8F101Q35652657-DAFAE652-9B5C-4F42-93EC-4DE41E115680Q35742537-02569F44-9F42-44C9-A249-4CD69449152CQ35793705-18A349E8-9A18-4474-AF25-565FE67D6747Q35856845-D752F4A2-A56A-44EC-996E-A57A42A12DFEQ36163659-97BAEA4D-36DC-4586-A96E-3C4957EB4268Q36302008-6B01AA23-414A-44A9-BDDA-66E93061062DQ36394208-4367FD56-EDA3-422A-905F-6ED5D0F83863Q36457427-373F9968-6B56-4D51-9771-71C0E6A115D3Q36464388-186CF6B0-3245-41DA-840F-2211FA3D441FQ36548047-0DEF3F8B-82B2-4561-A63B-199943BF1BE3Q36567898-B8A207E9-4374-4EFA-A103-F36A7EA88A5FQ36584397-DA190FDC-39D1-417B-A519-68CACC0C23D4Q36721411-9FB7F2E8-901E-4F2B-A1D9-AA73B1B336F6Q36732893-DE5372AA-60DA-4810-9492-6C7F50467A24Q37085879-D3DE5EE0-DB66-4D4A-8FE8-F059909EAE31Q37129860-F399F21D-CA18-44C0-8657-05CD01CED489Q37583117-D5589B0A-7569-49A6-B631-424493979697Q37657891-57EABD8A-051C-496F-8251-AF09FBC7F7D7Q37702543-F8442BAA-67F6-4DF0-8297-F55C8DBDCA6CQ37709418-1C4AF005-A23F-426B-81A0-9CD14A427770Q37800011-F8ABAF20-C860-4E2B-916C-E83D9DCCCCA1
P2860
Genome-wide DNA methylation profiles in precancerous conditions and cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genome-wide DNA methylation profiles in precancerous conditions and cancers.
@en
Genome-wide DNA methylation profiles in precancerous conditions and cancers.
@nl
type
label
Genome-wide DNA methylation profiles in precancerous conditions and cancers.
@en
Genome-wide DNA methylation profiles in precancerous conditions and cancers.
@nl
prefLabel
Genome-wide DNA methylation profiles in precancerous conditions and cancers.
@en
Genome-wide DNA methylation profiles in precancerous conditions and cancers.
@nl
P2860
P1433
P1476
Genome-wide DNA methylation profiles in precancerous conditions and cancers.
@en
P2093
P2860
P356
10.1111/J.1349-7006.2009.01383.X
P577
2009-10-01T00:00:00Z